- Home
- AGAE vs ICCC Comparison
AGAE vs ICCC Comparison
Compare AGAE & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGAE
- ICCC
- Stock Information
- Founded
- AGAE 2017
- ICCC 1982
- Country
- AGAE United States
- ICCC United States
- Employees
- AGAE N/A
- ICCC N/A
- Industry
- AGAE Cable & Other Pay Television Services
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- AGAE Telecommunications
- ICCC Health Care
- Exchange
- AGAE Nasdaq
- ICCC Nasdaq
- Market Cap
- AGAE 47.2M
- ICCC 39.2M
- IPO Year
- AGAE N/A
- ICCC 1987
- Fundamental
- Price
- AGAE $1.02
- ICCC $4.96
- Analyst Decision
- AGAE
- ICCC
- Analyst Count
- AGAE 0
- ICCC 0
- Target Price
- AGAE N/A
- ICCC N/A
- AVG Volume (30 Days)
- AGAE 19.9K
- ICCC 13.6K
- Earning Date
- AGAE 05-19-2025
- ICCC 05-13-2025
- Dividend Yield
- AGAE N/A
- ICCC N/A
- EPS Growth
- AGAE N/A
- ICCC N/A
- EPS
- AGAE N/A
- ICCC N/A
- Revenue
- AGAE $9,256,023.00
- ICCC $26,493,000.00
- Revenue This Year
- AGAE N/A
- ICCC N/A
- Revenue Next Year
- AGAE N/A
- ICCC N/A
- P/E Ratio
- AGAE N/A
- ICCC N/A
- Revenue Growth
- AGAE 36.15
- ICCC 51.63
- 52 Week Low
- AGAE $0.61
- ICCC $3.34
- 52 Week High
- AGAE $1.57
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- AGAE 43.33
- ICCC 49.78
- Support Level
- AGAE $1.08
- ICCC $4.56
- Resistance Level
- AGAE $1.11
- ICCC $5.05
- Average True Range (ATR)
- AGAE 0.05
- ICCC 0.27
- MACD
- AGAE -0.01
- ICCC 0.01
- Stochastic Oscillator
- AGAE 40.00
- ICCC 55.74
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.